Techniques to quantify TSH receptor antibodies (Q37198602)

18 August 2017

1 reference

title

Techniques to quantify TSH receptor antibodies (English)

1 reference

18 August 2017

1 reference

2

A P Weetman

1 reference

18 August 2017

R A Ajjan

1

1 reference

18 August 2017

24 June 2008

1 reference

Nature Clinical Practice Endocrinology and Metabolism

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

8

1 reference

18 August 2017

461-468

1 reference

Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

Long-acting thyroid stimulator: how receptor autoimmunity was discovered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyrotropin receptor-associated diseases: from adenomata to Graves disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyrotropin receptor antibodies: new insights into their actions and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyroid-stimulating immunoglobulins in Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Comparison of thyrotropin-receptor antibodies measured by four commercially available methods with a bioassay that uses Fisher rat thyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Autoantibodies interacting with purified native thyrotropin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Micromethod of human thyrocyte cultures for detection of thyroid-stimulating antibodies and thyrotrophin

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Detection of thyroid-stimulating antibody using frozen stocks of Chinese hamster ovary cells transfected with cloned human thyrotropin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Development of a luminescent bioassay for thyroid stimulating antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyroid controversy--stimulating antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves' disease: thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

1 reference

7 January 2021

Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Fetal thyroid function: diagnosis and management of fetal thyroid disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Therapy insight: management of Graves' disease during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

1 reference

7 January 2021

The Immunomodulatory Effects of Antithyroid Drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Serum Thyrotropin Receptor Antibodies Concentrations in Patients with Graves' Disease Before, at the End of Methimazole Treatment, and After Drug Withdrawal: Evidence That the Activity of Thyrotropin Receptor Antibody and/or Thyroid Response Modify D

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Effect of irradiation on thyroid-autoantibody production

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0886

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0886

1 reference

18 August 2017

1 reference

PubMed ID

18574503